"*Biota just received results so starting to attract interest...

"*Biota just received results so starting to attract interest for HRV. Will take 6-18 months to achieve a deal for HRV (closer to the 18 months according to PC).

*Possible deal metrics for HRV (at Phase II):
$50-$80m upfront
low double digit royalties"



This, IMO,could be, another lie by PC. After $20 Millions was spent on the Phase IIb studies and millions of free shares collected by them, now they tell shareholders to wait another 18 months before shareholders will POSSIBLY be presented with a more clear prospect for Vapendavir and some $$$. When the Phase IIb trial was in progress, we were told by the company that there were several big pharmas interested in Vapendavir. Now, it has almost been a half year since the positive trial result announced.